Families and patients are filing lawsuits against device maker Medtronic over its insulin pump, which they claim is defective and has resulted in fatal insulin overdoses. One pump was among over 400,000 recalled by the company in 2019 due to a fault that could lead to an over or under delivery of insulin, potentially causing severe harm or death. In response to the suits, Medtronic has denied its pump caused any deaths and requested a court motion for summary judgment.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
